Patient


  • Charlotte Owens, vice president, head of the Center for Health Equity and Patient Affairs, Takeda
    Image attribution tooltip
    Permission granted by Takeda
    Q&A

    Takeda’s global quest for health equity

    Takeda’s Center for Health Equity and Patient Affairs is built to address health inequality around the world and aims to raise the bar for the pharma industry.

    By Dec. 8, 2022
  • Overhead view of a person holding two white pills in their left hand and a glass of water in their right hand.
    Image attribution tooltip
    Stock via Getty Images
    Q&A

    Non-toxic and addiction free: The promise of a new pain med

    Why South Rampart Pharma’s novel new molecule could be a key to solving the global pain epidemic.

    By Dec. 1, 2022
  • pills
    Image attribution tooltip
    Stock via Getty Images

    10 of our most popular articles in 2022

    Methadone, rock ‘n’ roll, clinical trial overhauls — here’s a look at our most-read stories of the year.

    By Nov. 30, 2022
  • Nicole Lambert WoW picture
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Myriad Genetics’ Nicole Lambert

    Empowered by her own cancer journey, Nicole Lambert is using her platform as chief operating officer of the genetic testing powerhouse to change the trajectory of care for millions of women.

    By Nov. 23, 2022
  • Professional headshot of Sana Alajmovic.
    Image attribution tooltip

    Permission granted by Sana Alajmovic

    Profile

    A ‘bold vision’ to prevent diabetes

    Despite hearing that there’s “no money in prevention,” the CEO of Sigrid Therapeutics is forging ahead with the company’s goal of stopping Type 2 diabetes before it starts. 

    By Alexandra Pecci • Nov. 15, 2022
  • Glen de Vries blue origin
    Image attribution tooltip
    Permission granted by Medidata
    Q&A

    The legacy of Glen de Vries: Our last interview with the pioneering entrepreneur

    Recorded just weeks before his passing, our sit-down interview with the legendary medical sciences entrepreneur showcased his passion for pushing the industry toward its next frontier.

    By Nov. 11, 2022
  • IV infusion
    Image attribution tooltip
    Amornrat Phuchom via Getty Images

    While CAR-T wait times remain ‘heartbreaking,’ researchers push for innovations that could help

    Facing an unprecedented manufacturing bottleneck, a new coalition is aiming to create the next generation of CAR-T therapies.

    By Nov. 8, 2022
  • Disabilities
    Image attribution tooltip
    Stock via Getty Images
    Q&A

    The other ‘D’ in DE&I

    How companies can work to include people with disabilities into broader equity aims.

    By Nov. 4, 2022
  • Gulden Mesera wow pix
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: City of Hope’s Gulden Mesara

    Charged with bridging the 100-year-old research center to its future mission of holistic patient cancer care, Mesara is bringing decades of experience in communications and culture creation.

    By Nov. 2, 2022
  • diagram of man, doctor, phone, tablet
    Image attribution tooltip
    Retrieved from Google image.

    While DCTs get all the hype, some industry insiders say the future is a digital hybrid

    Leaders at Veeva believe the wording around decentralized trials has been exaggerated, and that a bigger-picture outlook is important as the pandemic winds down.

    By Nov. 1, 2022
  • A researcher with blue gloves holds a pipette tool in the right hand and a test tube in the left hand.
    Image attribution tooltip
    iStock via Getty Images

    Tips for tackling trial recruitment and retention woes in oncology

    How new tools are helping companies find and keep cancer patients in clinical studies.

    By Kelly Bilodeau • Oct. 31, 2022
  • woman sitting at a table counting money
    Image attribution tooltip
    HERO IMAGES via Getty Images
    Sponsored by GoodRx

    How does the Inflation Reduction Act affect healthcare?

    The Inflation Reduction Act helps support American families by lowering prescription drug prices and reducing overall healthcare costs.

    Oct. 31, 2022
  • Doug langa head shot
    Image attribution tooltip
    Permission granted by Doug Langa

    Backed by celebrity interest, Novo is finding new success in weight loss — while staying true to its roots

    The company's head of U.S. and Canadian operations explains how it’s evolving its game plan after 100 years in the insulin space.

    By Oct. 25, 2022
  • Women looking at phone
    Image attribution tooltip

    iStock.com/Shurkin Son

    Sponsored by Adheris Health

    Checking the box on digital engagement isn’t enough

    In a recent study, 50% of healthcare consumers reported that a bad digital experience can ruin the patient journey, while 39% felt that a good digital interaction had a positive influence.

    Oct. 24, 2022
  • Insomnia in healthcare
    Image attribution tooltip
    Stock via Getty Images
    Opinion

    What’s keeping pharma leaders up at night

    C-suite execs in the life sciences share their late-night thoughts including innovation, patient access and market factors.

    By Oct. 21, 2022
  • missing target
    Image attribution tooltip
    Stock via Getty Images

    5 impactful drug trial failures from the last year

    Major recent trial flops and what they mean for companies, patients and the industry.

    By Oct. 19, 2022
  • Charlotte Deane BW headshot
    Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Exscientia’s Charlotte Deane

    Is the industry ready for a biologic discovery revolution? Charlotte Deane, chief scientist of biologics AI at Exscientia, thinks so.

    By Oct. 19, 2022
  • woman checking her cell phone for provasic
    Image attribution tooltip
    Permission granted by GoodRx
    Sponsored by GoodRx

    Does your copay program factor in differences across specialties? GoodRx analysis shows it should.

    New findings reveal an out-of-pocket cost gap between brand-name and generic prescriptions. To address this gap, GoodRx is partnering with pharmaceutical companies to improve cost transparency and communication between patients and providers.  

    Oct. 17, 2022
  • Green capsule medicine pill fall out of a production line.
    Image attribution tooltip
    iStock via Getty Images

    Robotic pills could open a world of possibilities for the biologics market

    As the oral biologic market heats up, Rani Therapeutics is looking to dominate the field with its robotic pill for treatment of chronic conditions. 

    By Oct. 13, 2022
  • Amit Etkin horizontal
    Image attribution tooltip
    Permission granted by Amit Etkin
    Profile

    Harnessing the creative energy of California, Alto is advancing a novel approach to psychiatric meds

    After making the leap from academia to the world of biotech, CEO Dr. Amit Etkin is hoping to shift the treatment paradigm for neurological conditions.

    By Alexandra Pecci • Oct. 11, 2022
  • Silhouettes of two people colored in a swirling spectrum of colors. They are against a background of other spectrum colors and shapes.
    Image attribution tooltip
    Stan Eales via Getty Images
    Q&A

    New partnership may give MDMA an edge in the psychedelics space

    While LSD and psilocybin steal the spotlight, drug developers are also exploring MDMA for a wide swath of neurological illnesses. 

    By Kelly Bilodeau • Oct. 10, 2022
  • Doctor going over medical file with couple
    Image attribution tooltip
    Permission granted by CorEvitas
    Sponsored by CorEvitas

    Patient insights data

    While there are many sources of real-world evidence, there’s growing interest and focus on capturing patient generated insights to capture a more specific level of understanding for a given therapy.

    Oct. 10, 2022
  • Sponsored by Avant Healthcare

    The evolving roles and responsibilities of digital opinion leaders in medical education

    In the past, patients entrusted their healthcare providers to provide information about health-related matters.

    Oct. 3, 2022
  • magic mushroom
    Image attribution tooltip
    Stock via Getty Images
    Q&A

    Compass has the most advanced psychedelic drug in trials — but it needs a new approach to rollout to make it a success

    The company's CEO, Kabir Nath, discusses potential roadblocks to commecialization that await its psilocybin treatment for depression. 

    By Sept. 27, 2022
  • Autism stock
    Image attribution tooltip
    Stock via Getty Images
    Q&A

    Why precision medicine could be the next frontier in treating autism

    Swiss-based Stalicla is banking on an AI-driven precision medicine discovery platform to deliver needed therapies in the autism space.

    By Kelly Bilodeau • Sept. 27, 2022